SUZANNE SHUGG: Open Payments
NPI 1811997240 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,398 in 86 payments from 15 companies in 2025. Trend: 2023 $8,860 · 2024 $9,407 · 2025 $3,398
Speaker / faculty: $2,020Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $2,093 |
| Amgen Inc. | 19 | $294 |
| Novartis Pharmaceuticals Corporation | 23 | $261 |
| Novo Nordisk Inc | 11 | $197 |
| Boston Scientific Corporation | 7 | $150 |
| Lilly USA, LLC | 4 | $75 |
| Abbott Laboratories | 3 | $69 |
| Medtronic, Inc. | 2 | $65 |
| Ionis Pharmaceuticals, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $34 |
Products named: EVKEEZA, LEQVIO, Wegovy, REPATHA, CDS - MCT/CEM Monitoring, COREVALVE EVOLUT R, ZEPBOUND, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
